Category: CHC News

CMPI: Value of Prescription Drugs Is Underestimated

Pacira Files Complaint Calling FDA Marketing Restrictions Unconstitutional

CHC and CCC Launching Regulatory Compliance University for Agencies, Publishers

Amarin Federal Court Decision: FDA Off-Label Marketing Rules Violate the First Amendment By John Kamp

House Approves 21st Century Cures Act, Bill Now Heads to the Senate

Author of “Pharmaphobia” Says Conflict-of-interest Regulations Are Slowing Medical Progress

House Energy and Commerce Committee Wholeheartedly Approves 21st Century Cures Act

FDA Plans for Off-label Communication Draft Guidance, Meeting

PhRMA Authors Call for FDA to Establish Off-label Communication Safe Harbor